Aida Oliveros-Navarro

Aida Oliveros-Navarro

Auto-generated profile, based on publicly available information

Aida Oliveros-Navarro

Research Grupo Infettare, School of Medicine, Universidad Cooperativa Colombia, Calle 50, No 40-74, Bloque A, Medellín, Antioquia, 050012, Colombia, 57 3108406678

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 May 2025 in Journal of Medical Internet Research
Verified
Journal Article
Open access
DMDiana Carolina López Medina
Diana Carolina López Medina
AOAida Oliveros-Navarro
Aida Oliveros-Navarro
NMNataly Moreno-Ángel
Nataly Moreno-Ángel
AAAndrés Camilo Herrera- Arellano
Andrés Camilo Herrera- Arellano
MHMarcela Henao-Perez
Marcela Henao-Perez
Background: AI shows substantial potential in health care; however, the absence of standardized evaluation frameworks limits its safe and effective clinical implementation because of inconsistent validation requirements and fragmented ethical principles. Existing guidelines vary in structure, methodological rigor, and ethical integration, creating uncertainty. Objective: This study aimed to systematically map, characterize, and critically analyze existing evaluation frameworks for clinical AI, focusing on three core dimensions: methodological rigor, validation strategies (internal validation, including reporting of technical and clinical performance; external validation, including real-world applicability), and alignment with the United Nations Educational, Scientific and Cultural Organization (UNESCO) AI ethical considerations. Methods: A scoping review was conducted following PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews) guidelines. Six databases (PubMed, Embase, BVS, EBSCOhost, ProQuest, and Sage) and the Enhancing the Quality and Transparency of Health Research Network were searched without language or date restrictions up to February 2026. Eligible documents included peer-reviewed papers, gray literature, and organizational guidelines describing evaluation or reporting frameworks for clinical AI. Editorials, commentaries, and conference abstracts lacking a clearly defined evaluative framework or clinical applicability were excluded. Two reviewers independently screened records and extracted data. Data were extracted across three domains: (1) general characteristics, (2) methodological rigor and validation parameters, and (3) ethical integration and were synthesized using a dot plot–based gap map. Ethical adherence was assessed using a 10-domain UNESCO-based scoring matrix. No formal risk-of-bias assessment was conducted, consistent with scoping review methodology. Results: From 3363 records, 46 frameworks met the inclusion criteria. Mapping revealed a rapidly expanding but fragmented landscape. Most frameworks targeted investigational use (88%), with limited focus on clinical applicability. Frameworks varied in structure, methodology, and scope, with a predominance of reporting guidelines and few validated tools. Most (63%) were developed through multi-institutional collaborations, and 32.6% incorporated transdisciplinary participation. Only 31.8% reported technical metrics (commonly area under the curve, sensitivity, and specificity), and 15.9% provided clinical indicators (eg, predictive values or calibration). Only 11.4% achieved methodological rigor, incorporating validation aligned with intended use, while most relied on partial validation strategies, highlighting a gap between model development and clinical evaluation. Ethical integration was heterogeneous: only 5 frameworks achieved high compliance (≥80%), whereas 4 scored <10%. The most frequently addressed UNESCO principles were awareness and education (71.1%) and transparency and explainability (70%), while human oversight (24.4%) and adaptive governance (33.3%) were least represented. Findings indicate a misalignment between framework design, validation requirements, and clinical implementation. Conclusions: Evaluation frameworks for clinical AI remain heterogeneous and oriented toward investigational contexts. Critical gaps persist in methodological rigor, validation aligned with intended use, and fragmented ethical coverage. These findings highlight the need for standardized, robust, and ethically grounded frameworks to enable safe, reliable, and scalable integration of AI into clinical practice.

6 November 2024 in Biomédica
Verified
Journal Article
Open access
PDF file
AOAida Oliveros
Aida Oliveros
PFPaula Andrea Fonseca
Paula Andrea Fonseca
CRCarlos Andrés Rodríguez
Carlos Andrés Rodríguez
JGJavier Mauricio González
Javier Mauricio González
Los virus herpes simple (Herpes Simplex Virus, HSV) de tipo 1 y 2 producen la infección de transmisión sexual más común en mujeres, con mayor incidencia en los países en desarrollo. Además de generar secuelas principalmente neurológicas en el recién nacido, cuando la primoinfección ocurre durante el periodo perinatal, puede diseminarse y producir gran morbimortalidad de la madre y el neonato.A pesar de contarse con pruebas de laboratorio confiables, el diagnóstico de la infección por HSV durante el periodo perinatal es complejo, pues sus manifestaciones clínicas varían desde la forma diseminada hasta la asintomática o se pueden producir síntomas inespecíficos sin lesiones en piel o mucosas, por lo que es fundamental tener la sospecha clínica. Se presenta el caso de una madre con infección diseminada por HSV de tipo 2 que presentó hepatitis viral y cuyo neonato falleció, resaltándose la importancia de sospechar la infección por HSV en una mujer gestante febril con compromiso sistémico durante el periodo perinatal, aun en ausencia de brote.